Funding for this research was provided by:
Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada
Received: 22 August 2020
Accepted: 2 April 2021
First Online: 11 May 2021
: Clinical PCa tissue was collected from the participants of the Dynamics of androgen receptor genomics and transcriptomics after neoadjuvant androgen ablation study (ClinicalTrials.gov #NCT03297385). The trial was approved by the IRB of the Netherlands Cancer Institute. Informed consent was signed by all participants enrolled in the study and all research was carried out in accordance with relevant guidelines and regulations. All experimental methods comply with the Helsinki Declaration.
: Not applicable
: The authors declare that they have no competing interests.